Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma

Autologous stem cell transplant (ASCT) is the standard of care in transplant-eligible multiple myeloma patients and is associated with significant improvement in progression-free survival (PFS), complete remission rates (CR), and overall survival (OS). However, majority of patients eventually relaps...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mansour, Zeina, Ramanathan, Muthalagu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265378/
https://www.ncbi.nlm.nih.gov/pubmed/25525435
http://dx.doi.org/10.1155/2014/652395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265378/
https://www.ncbi.nlm.nih.gov/pubmed/25525435
http://dx.doi.org/10.1155/2014/652395

Ejemplares similares